OTC - ACTIVE INGREDIENT SECTION
red ginseng
red ginseng
scale calamus, rachis
to help the treatment of incurable diseases, various cancer, symptoms of atopy due to immuno deficiency
keep out or reach of the children
take 3 tablets a day (immediately after having breakfast and dinner)
if you take any serious medications or medical condition, consult your doctor
for oral use only
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 58912-2001-1 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4d70-60a7-e053-dbdaa90a05bd | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58912-2001-1 | Mirapharm-22 | 90 in 1 PACKAGE | CAPSULE | 90 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 58912-2001 | MIRAPHARM-22 (PANAX GINSENG WHOLE) CAPSULE [UNI BIO-TECH INC ] | 1 | Legacy NDC, 1 package rows | 20131117_a0b0911f-4021-4ef9-861f-f53dd371845b.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PANAX GINSENG WHOLE | ACTIVE INGREDIENT | 9L5JEP7MES | 1 | |
| PANAX GINSENG WHOLE | ACTIVE MOIETY | 9L5JEP7MES | 1 | |
| CALAMUS OIL | INACTIVE INGREDIENT | 5F9K5X640P | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 58912-2001 | 58912-2001-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PANAX GINSENG WHOLE | 9L5JEP7MES | ACTIB |
| CALAMUS OIL | 5F9K5X640P | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 9994cd61-f81f-48f4-a699-69a033d85a32 | a0b0911f-4021-4ef9-861f-f53dd371845b | 2013-11-16 | Warnings | 9994cd61-f81f-48f4-a699-69a033d85a32 a0b0911f-4021-4ef9-861f-f53dd371845b |
Adverse event summaries are temporarily unavailable. Other product information remains available.